- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04335734
Influence of Wrap Fixation Technique on the Results of Fundoplication
April 2, 2020 updated by: Grubnik Volodymyr
Patients who underwent anti-reflux surgery were divided into two groups.
In the I group Nissen fundoplication was supplemented with suturing wrap to the crura or the body of stomach using two non-absorbable stitches on each side.
Control group included patients who underwent classic Nissen fundoplication without wrap fixation.
All patients were assessed before and after surgery using validated symptoms and quality of life (GERD-HRQL) questionnaires, 24-h impedance-pH monitoring and barium-swallow.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
138
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 20 - 80 years;
- Gastroesophageal reflux disease as evidence by gastroscopy and pH-monitoring;
- HH type I, II
Exclusion Criteria:
- Age < 20 years and > 80 years;
- Unable to undergo laparoscopic fundoplication due to: severe comorbidities (ASA III and more), previous major surgery with severe adhesions, etc.;
- HH type III, IV;
- BMI < 16 and > 45 kg/m²;
- Pregnancy (in females);
- Oesophageal motility disorders;
- Oesophageal peptic strictures;
- Oesophageal diverticula, other types (i.e. non-reflux) of chronic esophagitis, connective tissue disorders (e.g. scleroderma);
- History of oesophageal/gastric/duodenal surgery including vagotomy;
- Relapsing course of ulcer disease/hyperacid gastritis including complicated by delayed gastric/duodenal emptying
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Nissen fundoplication with fixation of the wrap
In this arm, which included 87 patients we performed the following manipulations: NF was supplemented with suturing wrap to the diaphragmatic crura (52 patients) on each side using two non-absorbable stitches.
In case of weak conditions of crura or short esophagus (35 patients) fundoplication wrap was sutured to the body of stomach using two non-absorbable stitches on each side. .
|
Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization.
Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 сm² otherwise mesh for reinforcement of cruroraphy was used.
Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures.
Wrap was fixated to both diaphragmatic crura or to the body of stomach using two non-absorbable stitches on each side.
|
Active Comparator: Nissen fundoplication without fixation of the wrap
Arm included 51 patients, who underwent classic Nissen fundoplication without wrap fixation.
|
Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization.
Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 сm² otherwise mesh for reinforcement of cruroraphy was used.
Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recurrence rate of hiatal hernia
Time Frame: 60 months
|
Recurrence of hiatal hernia will be assessed by barium contrast swallow study
|
60 months
|
Slipped wrap
Time Frame: 60 months
|
Slipped wrap will be assessed by barium contrast swallow study
|
60 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life and satisfaction
Time Frame: 60 months
|
Quality of life and satisfaction will be assessed by Gastroesophageal reflux disease - health-related quality of life (GERD-HRQL) score.
The scale has 11 items,each item is scored from 0 to 5. A higher score indicating a better quality of life.
|
60 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2012
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
May 28, 2019
Study Registration Dates
First Submitted
April 2, 2020
First Submitted That Met QC Criteria
April 2, 2020
First Posted (Actual)
April 6, 2020
Study Record Updates
Last Update Posted (Actual)
April 6, 2020
Last Update Submitted That Met QC Criteria
April 2, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ONMedU 1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastro Oesophageal Reflux Disease
-
NorgineCompletedAcid Reflux | Gastro Oesophageal Reflux DiseaseUnited Kingdom
-
Imperial College LondonCompletedGastro-oesophageal Reflux DiseaseUnited Kingdom
-
Institute of Child HealthCompletedGastro-Oesophageal RefluxUnited Kingdom
-
Reckitt Benckiser Healthcare (UK) LimitedCompletedEsophagitis | Gastro Oesophageal Reflux DiseaseIreland
-
Studio Osteopatico Busto ArsizioRecruitingGastro-oesophageal Reflux DiseaseItaly
-
SOFAR S.p.A.CompletedGastro-oesophageal Reflux DiseaseItaly
-
Janssen-Cilag International NVCompletedGastroesophageal Reflux Disease | GERD | Gastro-oesophageal Reflux | Gastro-Esophageal Reflux | Esophageal Reflux
-
Manchester University NHS Foundation TrustCompletedGastro-oesophageal RefluxUnited Kingdom
-
Showa Inan General HospitalWithdrawnGastro-oesophageal RefluxJapan
Clinical Trials on Nissen Fundoplication with wrap fixation
-
Turku University HospitalCompleted
-
Federal University of São PauloHospital State PublicCompletedGastroesophageal RefluxBrazil
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainRecruitingCancer | Cachexia | Adipose TissueBelgium
-
Institute of Child HealthCompletedGastro-Oesophageal RefluxUnited Kingdom
-
Johns Hopkins UniversityCompletedGastroesophageal RefluxUnited States
-
Implantica CE Reflux Ltd.RecruitingGastroesophageal Reflux Disease (GERD)Switzerland, Germany
-
Mayo ClinicThe University of Texas Health Science Center, Houston; University of Southern... and other collaboratorsRecruitingHiatal Hernia | GERDUnited States
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)CompletedGastroesophageal Reflux | Idiopathic Pulmonary FibrosisUnited States
-
University of UtahCompletedNervous System Diseases | Gastroesophageal Reflux | Enteral Nutrition | FundoplicationUnited States
-
Chinese University of Hong KongUnknownGastroesophageal Reflux DiseaseHong Kong